AFPric & Saint-Etienne University Hospital | MethoFolic | IRD | Survey

This AFPric survey targets individuals living with rheumatoid arthritis, treated with methotrexate and folic acid supplementation, aged 18 or older. It aims to assess satisfaction with treatment administration and whether alternative methods might be helpful or more convenient.

Distributed by AFPric from October 25 to November 8, 2023, this survey collected responses from 1,238 individuals.

Role of Alsinova: Optimization of the questionnaire, regulatory registration, survey distribution, and statistical data analysis.

Associated publications: (Abstract) E. Dalix, N. Hamamouche, I. Pico Philippe, S. Rollot, H. Marotte. Taking folic acid at the same time as methotrexate could reduce folic acid non-compliance and simplify treatment administration in rheumatoid arthritis. POS1510-HPR. EULAR 2024. 12–15 June 2024, Vienna, Austria.